Back to list
Drug discovery · Pharmacology and safety modelling

ADMET and computational toxicology

Integrate structural alerts, property models, analogues and network evidence to triage absorption, distribution, metabolism, excretion and toxicity risks.

Discuss your research question
Original scientific visual for ADMET and computational toxicology
01
OVERVIEW

What ADMET and computational toxicology is designed to address

ADMET and computational toxicology is not a one-score software run. It is a reviewable analysis path organised around “Which developability or safety risks should be prioritised before experiments?”, beginning with input quality, comparators and intended use of evidence before selecting an appropriate methodological level.

The work centres on Physicochemical and ADMET prediction, Structural alerts and metabolism-site analysis, Toxicity targets, pathways and evidence grading and links Standardised chemical structures, Project stage and risk thresholds, Optional experimental and analogue data directly to Multidimensional property and risk overview, High-risk motifs with evidence sources, Experimental validation and optimisation suggestions. Reporting separates supporting evidence, conflicting signals, parameter dependence and conditions for follow-up validation.

Which developability or safety risks should be prioritised before experiments?

Suitable research settings

  • Projects that need to answer “Which developability or safety risks should be prioritised before experiments?”
  • Studies requiring consistent comparison and quality control across Physicochemical and ADMET prediction and Structural alerts and metabolism-site analysis
  • Teams that need Multidimensional property and risk overview, High-risk motifs with evidence sources, Experimental validation and optimisation suggestions with complete reproduction records
02
SERVICE SCOPE

Analyses included in the service

Physicochemical and ADMET prediction

Apply Physicochemical and ADMET prediction to standardised chemical structures and produce multidimensional property and risk overview. First confirm that standardised chemical structures can support the downstream analysis.

Structural alerts and metabolism-site analysis

Apply Structural alerts and metabolism-site analysis to project stage and risk thresholds and produce high-risk motifs with evidence sources. Use consistent systems, conditions and naming across adjacent steps so comparisons remain reviewable.

Toxicity targets, pathways and evidence grading

Apply Toxicity targets, pathways and evidence grading to optional experimental and analogue data and produce experimental validation and optimisation suggestions. Use consistent systems, conditions and naming across adjacent steps so comparisons remain reviewable.

03
METHOD SELECTION

Select the methodological level for the question

MethodBest suited toWatch for
Physicochemical and ADMET predictionEstablishing the input baseline and initial search space for ADMET and computational toxicologyErrors in ADMET and computational toxicology input state, structure or data definition propagate through later steps
Structural alerts and metabolism-site analysisComparing candidate states, features or mechanisms in ADMET and computational toxicology to form prioritiesADMET and computational toxicology comparisons require consistent conditions; raw scores are not experimental measurements
Toxicity targets, pathways and evidence gradingReviewing key ADMET and computational toxicology results, interpreting differences and recording uncertaintyComputational toxicology is risk triage and does not replace compliant in-vitro, in-vivo or clinical safety assessment.
04
WORKFLOW

From question definition to reproducible delivery

  1. Frame the research question

    Use “Which developability or safety risks should be prioritised before experiments?” to define comparators, decision use, experimental context and the strength of evidence the computation can support.

  2. Review and curate inputs

    Review Standardised chemical structures, Project stage and risk thresholds, Optional experimental and analogue data; resolve structure, naming, unit, batch or microstate issues and record any remaining assumptions.

  3. Design methods and controls

    Combine Physicochemical and ADMET prediction, Structural alerts and metabolism-site analysis, Toxicity targets, pathways and evidence grading with controls, replicates, sensitivity checks or independent evidence, defining decision criteria before computation.

  4. Compute with quality control

    Run ADMET and computational toxicology, including Physicochemical and ADMET prediction, in a reproducible environment; retain inputs, versions, parameters, logs and intermediate outputs, and flag convergence, sampling, data-quality and applicability issues.

  5. Interpret and deliver

    Organise Multidimensional property and risk overview, High-risk motifs with evidence sources, Experimental validation and optimisation suggestions while separating direct observations, model inference and working hypotheses, then prioritise experiments or follow-up computation.

05
INPUTS & DELIVERABLES

What is needed and what is delivered

Inputs

  • Standardised chemical structures
  • Project stage and risk thresholds
  • Optional experimental and analogue data

Optional supporting inputs

  • Known positive, negative or reference systems for basic expectation checks in ADMET and computational toxicology
  • Replicate experiments, external databases or literature evidence relevant to ADMET and computational toxicology
  • Timing, compute, software-compatibility or delivery-format constraints for ADMET and computational toxicology

Deliverables

  • Multidimensional property and risk overview
  • High-risk motifs with evidence sources
  • Experimental validation and optimisation suggestions
06
QUALITY CONTROL

Quality control and interpretation limits

How results are reviewed

  • ADMET and computational toxicology: Standardise chemical structures, target states and assay context
  • ADMET and computational toxicology: Review against known actives, decoys or simple baselines
  • ADMET and computational toxicology: Record applicability domain, score agreement and uncertainty
  • ADMET and computational toxicology: Check diversity, synthesizability and experimental testability

Boundaries that remain

  • Computational toxicology is risk triage and does not replace compliant in-vitro, in-vivo or clinical safety assessment.
  • ADMET and computational toxicology results apply only to the recorded inputs, parameters, models and sampling scope. Changes to input state, comparison conditions or project objectives may require new computation.
07
PROJECT PATTERNS

Common ways projects begin

From one system to comparable candidates

When standardised chemical structures are available but decision criteria are inconsistent, establish baselines and controls, then use Physicochemical and ADMET prediction, Structural alerts and metabolism-site analysis, Toxicity targets, pathways and evidence grading to build candidate tiers and deliver multidimensional property and risk overview with a difference analysis.

Independent review of existing results

When results relevant to ADMET and computational toxicology conflict, revisit standardised chemical structures and analytical assumptions around Physicochemical and ADMET prediction, then add replicates, sensitivity checks or alternative models to distinguish signal from method conditions.

08
FAQ

Questions before a project begins

What is required before ADMET and computational toxicology begins?

The minimum inputs are Standardised chemical structures, Project stage and risk thresholds, Optional experimental and analogue data. If information is incomplete, an input audit identifies which gaps change method selection and which can be handled as explicit assumptions.

Can the result directly prove “Which developability or safety risks should be prioritised before experiments?”?

No single model output should be treated as experimental fact. Computational toxicology is risk triage and does not replace compliant in-vitro, in-vivo or clinical safety assessment. Quality controls determine whether results support a priority or mechanism hypothesis; key conclusions still require appropriate experiments or independent data.

Which reusable files are delivered?

Typical delivery includes Multidimensional property and risk overview, High-risk motifs with evidence sources, Experimental validation and optimisation suggestions, together with input-curation records, key parameters, software and database versions, quality-control results, editable figures and limitations. Exact raw formats are confirmed in the project plan.

START WITH THE QUESTION

Describe your research question and we will evaluate the right computational path

Start a project